Herein,
an unprecedented [4 + 2] cycloaddition of enaminone with
1,3,5-triazinane has been developed. The representative semihydrogenated
aromatic heterocycle 1,2,3,4-tetrahydropyrimidines have been synthesized
with a broad substrate scope, demonstrating potential antitumor activity.
This approach has been smoothly conducted under additive-free and
environmentally friendly conditions that are compatible with various
functional groups. Furthermore, the condition optimization process
reveals that the tetrahydropyrimidine product is regulated via the
reaction temperature.